CP-185 The importance of assessing asymptomatic bacteriuria in hospitalised patients von Filip, OL, Calina, CD, Bocsaru, C, Docea, A, Mitrut, P, Bubulica, MV, Balasoiu, M, Zlatian, O, Rosu, L, Rosu, A

Volltext

DI-064 Study concerning adverse drug reactions in adult patients from surgical wards in a clinical emergency hospital von Filip, OL, Calina, CD, Docea, A, Mitrut, P, Bubulica, MV, Balasoiu, M, Rosu, A, Zlatian, O, Rosu, L, Bocsaru, C

Volltext

DI-062 Sustained virologic response rates of new direct acting antiviral agents for HCV von Caballero Requejo, C, Candela, M Onteniente, Miguel, JJ Franco, Coronel, M Garcia, Ruiz, A Trujillano, Candel, M Gil, Saez, C Garcia-Molina, Rodriguez-Hermida, F Artime

Volltext

CP-187 Knowledge of HIV infected patients on antiretroviral therapy and HIV infection von Esteban, L López, Blas, C Martín, Sastre, B Reques, González, A Onteniente, Ferrández, J Sánchez-Rubio, García, T Molina

Volltext

DI-063 Survival benefit with vemurafenib in ‘braf’ mutation positive melanoma: Area under the curve based reanalysis von Fenix-Caballero, S, Diaz-Navarro, J, Camean-Castillo, M, Rey, EJ Alegre-del, Palomo-Palomo, C, Blanco-Castaño, MA, Borrero-Rubio, JM, Gandara-LadronDeGuevara, MJ, GarciaDeParedes-Esteban, JC, Gil-Sierra, D

Volltext

CP-186 Can the antiretroviral therapy effectiveness be connected with treatment simplification? von Ferreira, J, Ferrer, C, Cândido, S, Moreira, S, Jorge, A, Carvalho, M, Branco, J, Glória, F, Oliveira, C

Volltext

DI-065 Safety of dabrafenib: Analysis of data from italian spontaneous reporting database von Langella, R, Festinese, F, Re, B, Lanzo, G, Togliardi, E, Nurra, S, Antonacci, G, Di Mauro, C, Mazzer, M, Saibene, G

Volltext